We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 5,250,905 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/5/2019 07:53 | BGF is an investment partner for growing companies in every sector of the economy. We provide the tools you need to grow, from funding to expertise, while letting you set the course.We believe in the power of brilliant businesses to drive innovation, generate progress and deliver prosperity. And we thrive in our role to help make that happen.Importantly they can be a source of funding. This looks really promising imo. Gla | jmf69 | |
14/5/2019 07:39 | Commenting on the announcement, Chris Meredith, CEO of AMS, said: "LiquiBand(R) Fix8(TM)has been growing sales strongly and receiving very positive feedback from surgeons in the European market and we are delighted that we can now start a study with our proprietary device that could benefit patients in the US market. Innovation is at the heart of AMS and this is just one example of our devices that helps patients, surgeons and healthcare payors. We look forward to reporting on further development with LiquiBand(R) Fix8(TM) as it grows sales and receives further approvals." | jmf69 | |
14/5/2019 07:09 | Rns from ams too regarding the progress of liquiband fix8 approval in the USA | jmf69 | |
14/5/2019 07:01 | Hopefully the start of institutions returning to the stock. | bjfanc | |
14/5/2019 06:34 | Interesting if it’s British growth fund as it looks? I wonder who has been selling, bgf’s model is usually to take a much bigger slice with the view of growing and selling the business, they usually want a seat on the board also | bashor | |
13/5/2019 22:04 | BGF acquired 3.2% if I'm reading it right | jmf69 | |
13/5/2019 21:56 | Holding rns | jmf69 | |
13/5/2019 17:25 | I purchased Pace & Sun with my redundancy, they were my first two holdings. | gbh2 | |
13/5/2019 14:59 | You forget I was a long term Pace sufferer ihabethe stamina :) | bashor | |
13/5/2019 13:28 | It's only the first 15 years that get you down Bashor, plain sailing now :)) | gbh2 | |
13/5/2019 11:08 | And they can still only offer 3.96p | bashor | |
12/5/2019 17:02 | POST REMOVED | buywell2 | |
10/5/2019 17:19 | Another 3.9m shares have been picked up by the buyer @ 3.98p | bashor | |
10/5/2019 11:39 | All looks very very promising, I’ve increased my sell order to 4.95p what was I saying about greed | bashor | |
10/5/2019 10:34 | Could lead to a chunky initial order into the USA market? | jmf69 | |
10/5/2019 10:33 | Ties in with someone wanting huge amounts of sun stock | jmf69 | |
10/5/2019 10:30 | I see the approval was granted on the 29th of April | bashor | |
10/5/2019 10:28 | POST REMOVED | buywell2 | |
10/5/2019 10:22 | POST REMOVED | buywell2 | |
10/5/2019 10:22 | https://www.accessda | jmf69 | |
10/5/2019 10:20 | Google yelloport elite for results in the last month | jmf69 | |
10/5/2019 10:11 | POST REMOVED | buywell2 | |
10/5/2019 09:50 | POST REMOVED | buywell2 | |
10/5/2019 09:41 | Could you point me to the 510K FDA notice please | bashor | |
10/5/2019 09:19 | I'm optimistic with the new board and new products. I notice the 510k premarket notification for yelloport Elite.This could be huge in the USA along with UK sales of cellis and dexter. | jmf69 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions